Risk stratification of metabolic dysfunction-associated steatotic liver disease: The KASL pathway: Editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease”
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Korean Association for the Study of the Liver
2026-01-01
|
| Rangatū: | Clinical and Molecular Hepatology |
| Ngā marau: | |
| Urunga tuihono: | http://e-cmh.org/upload/pdf/cmh-2025-0420.pdf |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|